DOCSLIB.ORG

Alt Haplotypes Refseq Curated Sequences Snps Dnase Clusters

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Alt Haplotypes Refseq Curated Sequences Snps Dnase Clusters Scale 50 Mb hg19 chr13: 50,000,000 100,000,000 Haplotypes to GRCh37 Reference Sequence Patches to GRCh37 Reference Sequence gl582975.1 Reference Assembly Alternate Haplotype Sequence Alignments Alt Haplotypes UCSC Genes (RefSeq, GenBank, CCDS, Rfam, tRNAs & Comparative Genomics) LINC00417 RNF17 MEDAG U6 U6 ESD NEK5 7SK PCDH9 MZT1 RBM26 MIR4500 GPC6 7SK DAOA ING1 DQ586768 RNF17 HSPH1 ALG5 DGKH ESD NEK3 DIAPH3 PCDH9 BORA RBM26 SLITRK5 GPC6 ZIC5 DAOA ING1 DQ579288 CENPJ HSPH1 ALG5 DGKH MED4 PRR20D PCDH9 BORA RBM26 SLITRK5 GPC6 ZIC2 DAOA ING1 DQ587539 CENPJ HSPH1 ALG5 DGKH MED4 PRR20D PCDH9 BORA RBM26 SLITRK5 DCT PCCA LIG4 F7 ANKRD20A9P CENPJ HSPH1 POSTN LACC1 RB1 PRR20D BC042366 BORA RBM26 LINC00433 DCT PCCA LIG4 F7 BC035261 CENPJ HSPH1 POSTN LACC1 RB1 PRR20B U7 DIS3 RBM26 LINC00353 DZIP1 FGF14 LIG4 F7 DQ572285 CENPJ HSPH1 POSTN SERP2 EBPL PRR20E PCDH9-AS2 DIS3 RBM26 LINC00559 OXGR1 TPP2 LIG4 F7 LINC00442 AMER2 RXFP2 UFM1 SERP2 EBPL PCDH17 PCDH9 DIS3 NDFIP2 MIR622 OXGR1 BIVM LIG4 F10 RNU6-52P AMER2 RXFP2 UFM1 TRNA BCMS PCDH17 LINC00550 UCHL3 SLITRK1 U6 OXGR1 BIVM LIG4 F10 TUBA3C AMER2 FRY UFM1 GTF2F2 BCMS PCDH17 KLHL1 LMO7 LINC00351 GPC5 IPO5 DAOA ING1 ANKRD26P3 RNF6 FRY FREM2 KCTD4 BCMS DIAPH3 KLHL1 LMO7 SLITRK6 Y_RNA IPO5 DAOA ING1 LINC00421 RNF6 FRY FREM2 KCTD4 BCMS DIAPH3 ATXN8OS LMO7 SLITRK6 5S_rRNA PCCA ABHD13 F10 TPTE2 RNF6 FRY NHLRC3 TPT1 BCMS DIAPH3 Y_RNA IRG1 MIR4500HG TRNA GGACT ABHD13 GRK1 TPTE2 RNF6 ZAR1L NHLRC3 TPT1 BCMS DIAPH3 LINC00348 IRG1 BC038529 MBNL2 BIVM MYO16 TPTE2 RNF6 BRCA2 NHLRC3 TPT1 BCMS DIAPH3 DACH1 CLN5 LINC00410 MBNL2 BIVM MYO16 TPTE2 CDK8 BRCA2 LHFP COG3 WDFY2 DIAPH3 DACH1 SCEL LINC00379 MBNL2 DAOA ING1 TPTE2 CDK8 BRCA2 COG6 COG3 WDFY2 DIAPH3 DACH1 SCEL MIR17HG RAP2A DAOA SOX1 TPTE2 CDK8 PDS5B COG6 COG3 WDFY2 TDRD3 SNORD37 SCEL MIR17HG IPO5 5S_rRNA MCF2L TPTE2 WASF3 PDS5B COG6 COG3 ATP7B TDRD3 SNORA9 NDFIP2 MIR19B1 IPO5 EFNB2 MCF2L MPHOSPH8 WASF3 KL 7SK CPB2 NEK3 TDRD3 PIBF1 SPRY2 DM119510 IPO5 ARGLU1 MCF2L MPHOSPH8 GPR12 KL FOXO1 CPB2 NEK3 TDRD3 PIBF1 SPRY2 GPC5-AS1 7SK ARGLU1 MCF2L MPHOSPH8 GPR12 RFC3 FOXO1 LCP1 NEK3 TDRD3 PIBF1 SPRY2 GPC5-AS1 DOCK9 FAM155A PROZ PSPC1 GPR12 RFC3 FOXO1 LCP1 THSD1 Y_RNA PIBF1 LINC00333 GPC6-AS2 GGACT 5S_rRNA GAS6 ZMYM5 USP12 RFC3 MRPS31 LCP1 THSD1 AK097816 KLF5 GPC5-AS1 DOCK9 SNORD31 PROZ ZMYM5 RPL21 U5 MIR621 LCP1 THSD1 MIR3169 KLF5 TRNA_Phe GGACT MYO16 ZMYM5 RPL21 NBEA WBP4 SUCLA2 DIAPH3-AS1 KLF12 TGDS TMTC4 MYO16 ZMYM5 GTF3A NBEA WBP4 SUCLA2 DIAPH3-AS1 KLF12 GPR180 NALCN IRS2 ZMYM2 GTF3A NBEA RGCC ITM2B DIAPH3-AS1 KLF12 GPR180 NALCN COL4A1 ZMYM2 GTF3A NBEA ELF1 SUCLA2 DIAPH3-AS1 KLF12 GPR180 NALCN COL4A2 ZMYM2 MTIF3 NBEA VWA8 RB1 DIAPH3-AS2 AX748190 Mir_562 NALCN RAB20 ZMYM2 MTIF3 NBEA ELF1 SUCLA2 DD413682 Mir_340 5S_rRNA FGF14 CARKD ZMYM2 MTIF3 NBEA VWA8 LPAR6 PCDH20 AK056689 SOX21 CCDC168 CARKD ZMYM2 MTIF3 DCLK1 DGKH LPAR6 PCDH20 AX747962 AK055459 TEX30 CARKD BC044596 MTIF3 DCLK1 DGKH LPAR6 OR7E156P LINC00381 BC045767 TEX30 CARKD ZMYM2 MTIF3 DCLK1 DGKH LPAR6 OR7E156P LINC00347 ABCC4 KDELC1 CARKD ZMYM2 LNX2 DCLK1 DGKH FNDC3A LOC647264 LINC00347 ABCC4 KDELC1 CARKD ZMYM2 LNX2 DCLK1 DGKH FNDC3A AK098560 CTAGE11P ABCC4 ERCC5 CARKD GJA3 POLR1D SOHLH2 EPSTI1 MLNR AK127969 TBC1D4 ABCC4 ERCC5 CARKD GJA3 POLR1D CCDC169 ENOX1 ARL11 AK057471 TBC1D4 ABCC4 ERCC5 CARKD GJB2 POLR1D CCDC169 ENOX1 EBPL BC128161 TBC1D4 ABCC4 ERCC5 CARS2 GJB2 POLR1D CCDC169 ENOX1 DLEU2 PCDH9-AS3 TBC1D4 ABCC4 SLC10A2 CARS2 GJB6 GSX1 CCDC169 ENOX1 PHF11 TBC1D4 ABCC4 DAOA-AS1 SPACA7 GJB6 PDX1 CCDC169 MGC5590 DLEU1 COMMD6 CLDN10 LINC00343 ATP11A GJB6 ATP5EP2 CCDC169 TSC22D1 BCMS COMMD6 CLDN10 LINC00460 MCF2L GJB6 CDX2 CCDC169 TSC22D1 BCMS COMMD6 CLDN10-AS1 LINC00551 MCF2L GJB6 PRHOXNB CCDC169 TSC22D1 BCMS UCHL3 CLDN10 LINC00443 PCID2 GJB6 FLT3 SPG20 TSC22D1 BCMS LMO7 DZIP1 BC043519 GAS6 CRYL1 FLT3 SPG20 TSC22D1 BCMS LMO7 DZIP1 TNFSF13B GAS6 CRYL1 FLT3 SPG20 TRNA_Glu BCMS LMO7 AK094990 TNFSF13B CDC16 CRYL1 PAN3 SPG20 NUFIP1 INTS6 LMO7 BC035106 TNFSF13B CDC16 CRYL1 PAN3 SPG20 KIAA1704 INTS6 AK123459 DNAJC3 MYO16-AS1 MIR4499 PAN3 SPG20 KIAA1704 INTS6 C13orf45 DNAJC3 COL4A2-AS1 IFT88 PAN3 SPG20OS KIAA1704 INTS6 KCTD12 UGGT2 DJ031140 IFT88 FLT1 SPG20OS KIAA1704 INTS6 KCTD12 UGGT2 LINC00346 IFT88 FLT1 CCNA1 KIAA1704 DHRS12 BTF3P11 UGGT2 DKFZp686B07190 IFT88 FLT1 CCNA1 KIAA1704 DHRS12 Mir_633 UGGT2 ANKRD10 IFT88 FLT1 CCNA1 SNORA31 ATP7B FBXL3 UGGT2 ANKRD10 IFT88 FLT1 CCNA1 DL489966 ATP7B MYCBP2 5S_rRNA ANKRD10 IL17D FLT1 CCNA1 D28408 ATP7B MYCBP2 HS6ST3 AK124233 AK055408 FLT1 CCNA1 TPT1-AS1 ATP7B MYCBP2 Metazoa_SRP ARHGEF7 N6AMT2 FLT1 SERTM1 TPT1-AS1 ATP7B MYCBP2-AS1 LINC00359 ARHGEF7 N6AMT2 FLT1 SERTM1 TPT1-AS1 ATP7B MYCBP2 DQ583891 ARHGEF7 N6AMT2 FLT1 5S_rRNA SLC25A30 ATP7B DKFZp586G0322 SNORD112 ARHGEF7 XPO4 FLT1 RFXAP SLC25A30 ATP7B Y_RNA MBNL2 ARHGEF7 XPO4 Y_RNA SMAD9 SLC25A30 ATP7B DQ588544 MBNL2 ARHGEF7 LATS2 POMP SMAD9 SLC25A30 ALG11 SLAIN1 MBNL2 ARHGEF7 LATS2 MTUS2 SMAD9 SLC25A30 VPS36 MIR3665 MBNL2 ARHGEF7 SAP18 MTUS2 EXOSC8 COG3 VPS36 SLAIN1 FARP1 ARHGEF7 SKA3 MTUS2 EXOSC8 FAM194B CKAP2 SLAIN1 FARP1 ARHGEF7 SKA3 MTUS2 POSTN FAM194B CKAP2 SLAIN1 FARP1 ARHGEF7 SKA3 SLC7A1 POSTN SPERT CKAP2 SLAIN1 RNF113B AX748212 MRP63 UBL3 POSTN SPERT CKAP2 SLAIN1 MIR3170 TEX29 MRP63 KATNAL1 POSTN SIAH3 SUGT1 SLAIN1 AF339801 AK055145 MIPEPP3 KATNAL1 POSTN ZC3H13 SUGT1 BC031243 AF339801 CR627049 MIPEPP3 HMGB1 POSTN ZC3H13 SUGT1 EDNRB AF339817 TUBGCP3 ZDHHC20 HMGB1 TRPC4 ZC3H13 LECT1 EDNRB STK24 TUBGCP3 ZDHHC20 HMGB1 TRPC4 ZC3H13 LECT1 EDNRB STK24 TUBGCP3 ZDHHC20 HMGB1 TRPC4 LRRC63 LECT1 EDNRB STK24 TUBGCP3 ZDHHC20 HMGB1 TRPC4 AY395526 PCDH8 RNF219-AS1 SLC15A1 C13orf35 ZDHHC20 USPL1 TRPC4 LRCH1 PCDH8 AK090854 SLC15A1 ATP11A MICU2 USPL1 TRPC4 LRCH1 OLFM4 LINC00446 DOCK9 BC041346 MICU2 USPL1 TRPC4 LRCH1 OLFM4 RNF219-AS1 DOCK9 AX748036 FGF9 USPL1 STOML3 LRCH1 MIR1297 POU4F1 DOCK9 ATP11A Metazoa_SRP TRNA_Asn STOML3 HTR2A MIR5007 RNF219 DOCK9 ATP11A LINC00424 ALOX5AP PROSER1 HTR2A TRNA_Pseudo RNF219 DOCK9 AK025511 AK054845 ALOX5AP AK021977 NUDT15 LINC00331 DOCK9 BC035340 BC035104 TEX26 MIR4305 NUDT15 HH834010 DOCK9 MCF2L-AS1 BC048997 HSPH1 LINC00598 RCBTB2 HH834010 DOCK9 PCID2 BASP1P1 HSPH1 MIR320D1 RCBTB2 RBM26-AS1 DOCK9 PCID2 SGCG B3GALTL SLC25A15 RCBTB2 RBM26-AS1 DOCK9 PCID2 SGCG B3GALTL SLC25A15 RCBTB2 NDFIP2-AS1 DOCK9 PCID2 SGCG EEF1DP3 TPTE2P5 RCBTB2 NDFIP2 DOCK9 PCID2 SACS EEF1DP3 TPTE2P5 RCBTB2 Mir_548 DOCK9 PCID2 SACS BC035084 TPTE2P5 RCBTB2 BC036310 DOCK9 CUL4A SACS BRCA2 SUGT1P3 CYSLTR2 UBAC2-AS1 CUL4A SACS N4BP2L1 ELF1 CYSLTR2 UBAC2-AS1 CUL4A SACS-AS1 N4BP2L1 TRNA_Glu CYSLTR2 UBAC2 AK126278 LINC00327 N4BP2L1 KBTBD6 FNDC3A UBAC2 CUL4A TNFRSF19 SNORA16 AK056182 FNDC3A UBAC2 LAMP1 TNFRSF19 N4BP2L2 KBTBD7 FNDC3A UBAC2 LAMP1 TNFRSF19 N4BP2L2 MTRF1 FNDC3A UBAC2 GRTP1 TNFRSF19 N4BP2L2 MTRF1 CDADC1 UBAC2 GRTP1 TNFRSF19 N4BP2L2 MTRF1 CDADC1 UBAC2 GRTP1 MIPEP N4BP2L2 MTRF1 CDADC1 MIR548AN GRTP1 MIPEP N4BP2L2 BC051736 CDADC1 GPR18 ADPRHL1 C1QTNF9B-AS1 HV983084 BC051736 CDADC1 GPR18 ADPRHL1 C1QTNF9B-AS1 MINOS1P1 MTRF1 CDADC1 GPR18 DCUN1D2 C1QTNF9B N4BP2L2 Mir_324 CAB39L GPR183 DCUN1D2 C1QTNF9B U50535 NAA16 CAB39L GPR183 DCUN1D2 C1QTNF9B PDS5B NAA16 CAB39L UBAC2 TMCO3 C1QTNF9B PDS5B NAA16 SETDB2 FKSG29 TMCO3 ANKRD20A19P PDS5B NAA16 SETDB2 MIR623 TFDP1 BC043582 BC026240 OR7E37P SETDB2 AK123584 TFDP1 SPATA13 STARD13 MIR5006 SETDB2 TM9SF2 TFDP1 SPATA13 STARD13 Mir_684 SETDB2 TM9SF2 TFDP1 SPATA13 STARD13 VWA8-AS1 PHF11 CLYBL TFDP1 SPATA13 STARD13 AK054970 PHF11 CLYBL TFDP1 SPATA13 STARD13 AKAP11 PHF11 CLYBL ATP4B MIR2276 STARD13 TNFSF11 PHF11 MIR4306 ATP4B SPATA13 STARD13 TNFSF11 RCBTB1 PCCA-AS1 LINC00552 SPATA13 LINC00457 FAM216B ARL11 TMTC4 TMEM255B SPATA13-AS1 MIR548F5 EPSTI1 KPNA3 TMTC4 TMEM255B SPATA13 TRNA_Pseudo CCDC122 DLEU2 TMTC4 GAS6-AS1 SPATA13 SUPT20H CPB2-AS1 TMTC4 FLJ41484 SPATA13 SUPT20H CPB2-AS1 NALCN-AS1 LOC100506394 SPATA13 SUPT20H LINC00563 ITGBL1 AK126042 SPATA13 SUPT20H AK123654 ITGBL1 BC068105 C1QTNF9 SUPT20H MED4-AS1 ITGBL1 LINC00565 BC038727 SUPT20H LINC00441 ITGBL1 RASA3 PARP4 SUPT20H LINC00462 MIR2681 RASA3 PARP4 SUPT20H CYSLTR2 MIR4705 RASA3 TPTE2P6 SUPT20H CYSLTR2 FGF14-IT1 RASA3 TPTE2P6 SUPT20H CYSLTR2 FGF14-IT1 RASA3 TPTE2P6 SUPT20H KIAA0226L FGF14-AS2 CDC16 ATP12A CSNK1A1L CYSLTR2 METTL21C CDC16 ATP12A LINC00547 CYSLTR2 AX747578 CDC16 RNF17 Mir_720 CYSLTR2 BIVM-ERCC5 CDC16 RNF17 LINC00571 CYSLTR2 METTL21EP UPF3A RNF17 LINC00366 CTAGE10P MIR548AS UPF3A RNF17 LINC00332 SPRYD7 UPF3A RNF17 LINC00548 SPRYD7 UPF3A RNF17 LINC00598 SPRYD7 UPF3A AK054988 LINC00598 SPRYD7 UPF3A TPTE2P1 TRNA_Glu MIR3613 CHAMP1 TPTE2P1 FAM216B TRIM13 CHAMP1 TPTE2P1 DNAJC15 TRIM13 CHAMP1 PABPC3 CCDC122 KCNRG CHAMP1 BC022569 LINC00284 DLEU1 MTMR6 SMIM2-IT1 DLEU1 MTMR6 AX748251 DLEU7 MTMR6 BC025370 DLEU7 MTMR6 TSC22D1-AS1 DHRS12 NUPL1 LINC00330 CCDC70 NUPL1 Metazoa_SRP MIR759 NUPL1 KIAA0226L ATP8A2 KIAA0226L ATP8A2 KIAA0226L ATP8A2 KIAA0226L ATP8A2 KIAA0226L ATP8A2 KIAA0226L SHISA2 KIAA0226L BC047364 KIAA0226L SNORD102 KIAA0226L SNORA27 Metazoa_SRP RASL11A TRIM13 PAN3-AS1 TRIM13 HV303147 TRIM13 HV303168 KCNRG BC048278 DLEU2 DD413682 DLEU2 SLC46A3 DLEU2 SLC46A3 DLEU2 SLC46A3 DLEU2 SLC46A3 MIR16-1 MTUS2-AS1 DM119508 LINC00297 DLEU2 LINC00544 DLEU1 LINC00426 DLEU1 LINC00398 DLEU1 TEX26-AS1 DLEU1 TEX26-AS1 DLEU1 DQ590719 DLEU1 DQ581687 DLEU1 DQ585583 DLEU1 DQ585215 ST13P4 DQ599653 SNORD112 DQ594776 DLEU7-AS1 DQ594776 RNASEH2B-AS1 DKFZp666K117 RNASEH2B N4BP2L2-IT2 RNASEH2B LINC00423 GUCY1B2 STARD13-AS GUCY1B2 CCDC169-SOHLH2 5S_rRNA LINC00371 LINC00371 FAM124A FAM124A FAM124A SERPINE3 SERPINE3 MIR5693 BC045725 D28359 MIR4703 LINC00282 LINC00282 CCDC70 CCDC70 UTP14C UTP14C UTP14C UTP14C MRPS31P5 MRPS31P5 MRPS31P5 MRPS31P5 MRPS31P5
Load more

Recommended publications
  • Human Astrocytes: Structure and Functions in the Healthy Brain
    Brain Struct Funct DOI 10.1007/s00429-017-1383-5 REVIEW Human astrocytes: structure and functions in the healthy brain Flora Vasile1 · Elena Dossi1 · Nathalie Rouach1 Received: 4 November 2016 / Accepted: 6 February 2017 © The Author(s) 2017. This article is published with open access at Springerlink.com Abstract Data collected on astrocytes’ physiology in the Introduction rodent have placed them as key regulators of synaptic, neu- ronal, network, and cognitive functions. While these find- Since the early discovery that the range of astroglial func- ings proved highly valuable for our awareness and appreci- tions extends considerably beyond passive structural sup- ation of non-neuronal cell significance in brain physiology, port, astrocytes have cemented their position as crucial early structural and phylogenic investigations of human determinants of proper neuronal function. Astrocytes are astrocytes hinted at potentially different astrocytic proper- now considered as full-fledged participants in brain cir- ties. This idea sparked interest to replicate rodent-based cuitry and processing, and display a large spectrum of studies on human samples, which have revealed an analo- functions at the cell level, such as the formation, matura- gous but enhanced involvement of astrocytes in neuronal tion and elimination of synapses, ionic homeostasis, clear- function of the human brain. Such evidence pointed to a ance of neurotransmitters, regulation of extracellular space central role of human astrocytes in sustaining more com- volume, and modulation of synaptic activity and plastic- plex information processing. Here, we review the current ity (Araque et al. 2014; Dallérac and Rouach 2016). It has state of our knowledge of human astrocytes regarding their additionally been demonstrated that they are involved in structure, gene profile, and functions, highlighting the dif- rhythm generation and neuronal network patterns (Fellin ferences with rodent astrocytes.
    [Show full text]
  • Transcriptomic Profiling of Ca Transport Systems During
    cells Article Transcriptomic Profiling of Ca2+ Transport Systems during the Formation of the Cerebral Cortex in Mice Alexandre Bouron Genetics and Chemogenomics Lab, Université Grenoble Alpes, CNRS, CEA, INSERM, Bâtiment C3, 17 rue des Martyrs, 38054 Grenoble, France; [email protected] Received: 29 June 2020; Accepted: 24 July 2020; Published: 29 July 2020 Abstract: Cytosolic calcium (Ca2+) transients control key neural processes, including neurogenesis, migration, the polarization and growth of neurons, and the establishment and maintenance of synaptic connections. They are thus involved in the development and formation of the neural system. In this study, a publicly available whole transcriptome sequencing (RNA-Seq) dataset was used to examine the expression of genes coding for putative plasma membrane and organellar Ca2+-transporting proteins (channels, pumps, exchangers, and transporters) during the formation of the cerebral cortex in mice. Four ages were considered: embryonic days 11 (E11), 13 (E13), and 17 (E17), and post-natal day 1 (PN1). This transcriptomic profiling was also combined with live-cell Ca2+ imaging recordings to assess the presence of functional Ca2+ transport systems in E13 neurons. The most important Ca2+ routes of the cortical wall at the onset of corticogenesis (E11–E13) were TACAN, GluK5, nAChR β2, Cav3.1, Orai3, transient receptor potential cation channel subfamily M member 7 (TRPM7) non-mitochondrial Na+/Ca2+ exchanger 2 (NCX2), and the connexins CX43/CX45/CX37. Hence, transient receptor potential cation channel mucolipin subfamily member 1 (TRPML1), transmembrane protein 165 (TMEM165), and Ca2+ “leak” channels are prominent intracellular Ca2+ pathways. The Ca2+ pumps sarco/endoplasmic reticulum Ca2+ ATPase 2 (SERCA2) and plasma membrane Ca2+ ATPase 1 (PMCA1) control the resting basal Ca2+ levels.
    [Show full text]
  • GJB2 and GJB6 Genetic Variant Curation in an Argentinean Non-Syndromic Hearing-Impaired Cohort
    G C A T T A C G G C A T genes Article GJB2 and GJB6 Genetic Variant Curation in an Argentinean Non-Syndromic Hearing-Impaired Cohort Paula Buonfiglio 1 , Carlos D. Bruque 2,3 , Leonela Luce 4,5, Florencia Giliberto 4,5, Vanesa Lotersztein 6, Sebastián Menazzi 7, Bibiana Paoli 8, Ana Belén Elgoyhen 1,9 and Viviana Dalamón 1,* 1 Laboratorio de Fisiología y Genética de la Audición, Instituto de Investigaciones en Ingeniería Genética y Biología Molecular “Dr. Héctor N. Torres”, Consejo Nacional de Investigaciones Científicas y Técnicas—INGEBI/CONICET, C1428ADN Ciudad Autónoma de Buenos Aires, Argentina; paulabuonfi[email protected] (P.B.); [email protected] (A.B.E.) 2 Centro Nacional de Genética Médica, ANLIS-Malbrán, C1425 Ciudad Autónoma de Buenos Aires, Argentina; [email protected] 3 Instituto de Biología y Medicina Experimental, Consejo Nacional de Investigaciones Científicas y Técnicas—IBYME/CONICET, C1428ADN Ciudad Autónoma de Buenos Aires, Argentina 4 Laboratorio de Distrofinopatías, Cátedra de Genética, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, C1113AAD Ciudad Autónoma de Buenos Aires, Argentina; [email protected] (L.L.); gilibertofl[email protected] (F.G.) 5 Instituto de Inmunología, Genética y Metabolismo—INIGEM/CONICET, Universidad de Buenos Aires, C1113AAD Ciudad Autónoma de Buenos Aires, Argentina 6 Servicio de Genética, Hospital Militar Central “Dr. Cosme Argerich”, C1426 Ciudad Autónoma de Buenos Aires, Argentina; [email protected] 7 Servicio de Genética, Hospital de Clínicas “José de San Martín”,
    [Show full text]
  • Ion Channels
    UC Davis UC Davis Previously Published Works Title THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels. Permalink https://escholarship.org/uc/item/1442g5hg Journal British journal of pharmacology, 176 Suppl 1(S1) ISSN 0007-1188 Authors Alexander, Stephen PH Mathie, Alistair Peters, John A et al. Publication Date 2019-12-01 DOI 10.1111/bph.14749 License https://creativecommons.org/licenses/by/4.0/ 4.0 Peer reviewed eScholarship.org Powered by the California Digital Library University of California S.P.H. Alexander et al. The Concise Guide to PHARMACOLOGY 2019/20: Ion channels. British Journal of Pharmacology (2019) 176, S142–S228 THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels Stephen PH Alexander1 , Alistair Mathie2 ,JohnAPeters3 , Emma L Veale2 , Jörg Striessnig4 , Eamonn Kelly5, Jane F Armstrong6 , Elena Faccenda6 ,SimonDHarding6 ,AdamJPawson6 , Joanna L Sharman6 , Christopher Southan6 , Jamie A Davies6 and CGTP Collaborators 1School of Life Sciences, University of Nottingham Medical School, Nottingham, NG7 2UH, UK 2Medway School of Pharmacy, The Universities of Greenwich and Kent at Medway, Anson Building, Central Avenue, Chatham Maritime, Chatham, Kent, ME4 4TB, UK 3Neuroscience Division, Medical Education Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK 4Pharmacology and Toxicology, Institute of Pharmacy, University of Innsbruck, A-6020 Innsbruck, Austria 5School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, BS8 1TD, UK 6Centre for Discovery Brain Science, University of Edinburgh, Edinburgh, EH8 9XD, UK Abstract The Concise Guide to PHARMACOLOGY 2019/20 is the fourth in this series of biennial publications. The Concise Guide provides concise overviews of the key properties of nearly 1800 human drug targets with an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties.
    [Show full text]
  • The Role of Potassium Recirculation in Cochlear Amplification
    The role of potassium recirculation in cochlear amplification Pavel Mistrika and Jonathan Ashmorea,b aUCL Ear Institute and bDepartment of Neuroscience, Purpose of review Physiology and Pharmacology, UCL, London, UK Normal cochlear function depends on maintaining the correct ionic environment for the Correspondence to Jonathan Ashmore, Department of sensory hair cells. Here we review recent literature on the cellular distribution of Neuroscience, Physiology and Pharmacology, UCL, Gower Street, London WC1E 6BT, UK potassium transport-related molecules in the cochlea. Tel: +44 20 7679 8937; fax: +44 20 7679 8990; Recent findings e-mail: [email protected] Transgenic animal models have identified novel molecules essential for normal hearing Current Opinion in Otolaryngology & Head and and support the idea that potassium is recycled in the cochlea. The findings indicate that Neck Surgery 2009, 17:394–399 extracellular potassium released by outer hair cells into the space of Nuel is taken up by supporting cells, that the gap junction system in the organ of Corti is involved in potassium handling in the cochlea, that the gap junction system in stria vascularis is essential for the generation of the endocochlear potential, and that computational models can assist in the interpretation of the systems biology of hearing and integrate the molecular, electrical, and mechanical networks of the cochlear partition. Such models suggest that outer hair cell electromotility can amplify over a much broader frequency range than expected from isolated cell studies. Summary These new findings clarify the role of endolymphatic potassium in normal cochlear function. They also help current understanding of the mechanisms of certain forms of hereditary hearing loss.
    [Show full text]
  • Abstracts from the 51St European Society of Human Genetics Conference: Electronic Posters
    European Journal of Human Genetics (2019) 27:870–1041 https://doi.org/10.1038/s41431-019-0408-3 MEETING ABSTRACTS Abstracts from the 51st European Society of Human Genetics Conference: Electronic Posters © European Society of Human Genetics 2019 June 16–19, 2018, Fiera Milano Congressi, Milan Italy Sponsorship: Publication of this supplement was sponsored by the European Society of Human Genetics. All content was reviewed and approved by the ESHG Scientific Programme Committee, which held full responsibility for the abstract selections. Disclosure Information: In order to help readers form their own judgments of potential bias in published abstracts, authors are asked to declare any competing financial interests. Contributions of up to EUR 10 000.- (Ten thousand Euros, or equivalent value in kind) per year per company are considered "Modest". Contributions above EUR 10 000.- per year are considered "Significant". 1234567890();,: 1234567890();,: E-P01 Reproductive Genetics/Prenatal Genetics then compared this data to de novo cases where research based PO studies were completed (N=57) in NY. E-P01.01 Results: MFSIQ (66.4) for familial deletions was Parent of origin in familial 22q11.2 deletions impacts full statistically lower (p = .01) than for de novo deletions scale intelligence quotient scores (N=399, MFSIQ=76.2). MFSIQ for children with mater- nally inherited deletions (63.7) was statistically lower D. E. McGinn1,2, M. Unolt3,4, T. B. Crowley1, B. S. Emanuel1,5, (p = .03) than for paternally inherited deletions (72.0). As E. H. Zackai1,5, E. Moss1, B. Morrow6, B. Nowakowska7,J. compared with the NY cohort where the MFSIQ for Vermeesch8, A.
    [Show full text]
  • Supplementary Table 2
    Supplementary Table 2. Differentially Expressed Genes following Sham treatment relative to Untreated Controls Fold Change Accession Name Symbol 3 h 12 h NM_013121 CD28 antigen Cd28 12.82 BG665360 FMS-like tyrosine kinase 1 Flt1 9.63 NM_012701 Adrenergic receptor, beta 1 Adrb1 8.24 0.46 U20796 Nuclear receptor subfamily 1, group D, member 2 Nr1d2 7.22 NM_017116 Calpain 2 Capn2 6.41 BE097282 Guanine nucleotide binding protein, alpha 12 Gna12 6.21 NM_053328 Basic helix-loop-helix domain containing, class B2 Bhlhb2 5.79 NM_053831 Guanylate cyclase 2f Gucy2f 5.71 AW251703 Tumor necrosis factor receptor superfamily, member 12a Tnfrsf12a 5.57 NM_021691 Twist homolog 2 (Drosophila) Twist2 5.42 NM_133550 Fc receptor, IgE, low affinity II, alpha polypeptide Fcer2a 4.93 NM_031120 Signal sequence receptor, gamma Ssr3 4.84 NM_053544 Secreted frizzled-related protein 4 Sfrp4 4.73 NM_053910 Pleckstrin homology, Sec7 and coiled/coil domains 1 Pscd1 4.69 BE113233 Suppressor of cytokine signaling 2 Socs2 4.68 NM_053949 Potassium voltage-gated channel, subfamily H (eag- Kcnh2 4.60 related), member 2 NM_017305 Glutamate cysteine ligase, modifier subunit Gclm 4.59 NM_017309 Protein phospatase 3, regulatory subunit B, alpha Ppp3r1 4.54 isoform,type 1 NM_012765 5-hydroxytryptamine (serotonin) receptor 2C Htr2c 4.46 NM_017218 V-erb-b2 erythroblastic leukemia viral oncogene homolog Erbb3 4.42 3 (avian) AW918369 Zinc finger protein 191 Zfp191 4.38 NM_031034 Guanine nucleotide binding protein, alpha 12 Gna12 4.38 NM_017020 Interleukin 6 receptor Il6r 4.37 AJ002942
    [Show full text]
  • 1 1 2 3 Cell Type-Specific Transcriptomics of Hypothalamic
    1 2 3 4 Cell type-specific transcriptomics of hypothalamic energy-sensing neuron responses to 5 weight-loss 6 7 Fredrick E. Henry1,†, Ken Sugino1,†, Adam Tozer2, Tiago Branco2, Scott M. Sternson1,* 8 9 1Janelia Research Campus, Howard Hughes Medical Institute, 19700 Helix Drive, Ashburn, VA 10 20147, USA. 11 2Division of Neurobiology, Medical Research Council Laboratory of Molecular Biology, 12 Cambridge CB2 0QH, UK 13 14 †Co-first author 15 *Correspondence to: [email protected] 16 Phone: 571-209-4103 17 18 Authors have no competing interests 19 1 20 Abstract 21 Molecular and cellular processes in neurons are critical for sensing and responding to energy 22 deficit states, such as during weight-loss. AGRP neurons are a key hypothalamic population 23 that is activated during energy deficit and increases appetite and weight-gain. Cell type-specific 24 transcriptomics can be used to identify pathways that counteract weight-loss, and here we 25 report high-quality gene expression profiles of AGRP neurons from well-fed and food-deprived 26 young adult mice. For comparison, we also analyzed POMC neurons, an intermingled 27 population that suppresses appetite and body weight. We find that AGRP neurons are 28 considerably more sensitive to energy deficit than POMC neurons. Furthermore, we identify cell 29 type-specific pathways involving endoplasmic reticulum-stress, circadian signaling, ion 30 channels, neuropeptides, and receptors. Combined with methods to validate and manipulate 31 these pathways, this resource greatly expands molecular insight into neuronal regulation of 32 body weight, and may be useful for devising therapeutic strategies for obesity and eating 33 disorders.
    [Show full text]
  • Whole Exome Sequencing Identified Mutations Causing Hearing Loss In
    Whole exome sequencing identied mutations causing hearing loss in ve consanguineous Pakistan families Yingjie Zhou Second Hospital of Hebei Medical University Muhammad Tariq National Institue for Biotechnology and Genetic Engineering Sijie He(Former Corresponding Author) BGI https://orcid.org/0000-0002-4418-1785 Uzma Abdullah NIBGE Jianguo Zhang(New Corresponding Author) ( [email protected] ) BGI Shahid Mahmood Baig NIBGE Research article Keywords: hearing loss, whole exome sequencing, consanguineous pedigrees, clinical detection Posted Date: April 8th, 2020 DOI: https://doi.org/10.21203/rs.2.19325/v2 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Version of Record: A version of this preprint was published on July 18th, 2020. See the published version at https://doi.org/10.1186/s12881-020-01087-x. Page 1/10 Abstract Background Hearing loss is the most common sensory defect that affects over 6% of the population worldwide. About 50%-60% of hearing loss patients are attributed to genetic causes. Currently more than 100 genes have been reported to cause non-syndromic hearing loss. It’s possible and ecient to screen all potential disease-causing genes for hereditary hearing loss by whole exome sequencing (WES). Methods We collected 5 consanguineous pedigrees with hearing loss from Pakistan and applied WES on selected patients for each pedigree, followed by bioinformatics analysis and Sanger validation to identify the causing genes for them. Results Variants in 7 genes were identied and validated in these pedigrees. We identied single candidate for 3 pedigrees, which were GIPC3 (c.937T>C), LOXHD1 (c.2935G>A) and TMPRSS3 (c.941T>C).
    [Show full text]
  • Molecular Test for Non Syndromic Hearing Loss
    Molecular Testing for Connexin 26 (GJB2) and Connexin 30 (GJB6) Mutations Associated with Non Syndromic Hearing Loss The UNC Hospitals Molecular Genetics Laboratory offers DNA sequencing of the coding region of the connexin 26 (GJB2) gene and analysis of deletions in the connexin 30 (GJB6) gene to detect mutations that are associated with hereditary nonsyndromic hearing loss. Biology of the disease : Profound congenital hearing loss affects approximately 1 in 1000 infants. Approximately 50% of cases have a genetic cause, and 70% of these genetic cases are classified as nonsyndromic, meaning that hearing loss is the only clinical finding. The remaining 30% have additional signs or symptoms with over 400 different syndromes described. Familial nonsyndromic hearing loss (NSHL) is primarily sensorineural, with the mode of inheritance being 77% autosomal recessive, 22% autosomal dominant, and the remainder X-linked or mitochondrial. Several genetic loci have been mapped, including the DFNB1 locus on chromosome 13q12 containing the gap junction beta 2 (GJB2) gene encoding connexin 26 protein and the GJB6 gene encoding connexin 30 protein. Connexins 26 and 30, transmembrane proteins expressed in the inner ear, form ion channels regulating intercellular communication. Numerous disease-causing mutations in GJB2 have been identified, the most common of which is 35delG, which is found in over two- thirds of Caucasians with DFNB1-linked hearing loss. It is estimated that 35delG is responsible for 10% of all deafness and 20% of all hereditary hearing impairment. Other mutations in GJB2 are more common in other ethnic groups; for example, 167delT accounts for majority of cases of autosomal recessive NSHL in people of Ashkenazi Jewish ethnicity.
    [Show full text]
  • Genetic Testing for Hereditary Hearing Loss
    MEDICAL POLICY POLICY TITLE GENETIC TESTING FOR HEREDITARY HEARING LOSS POLICY NUMBER MP-2.319 Original Issue Date (Created): 2/1/2014 Most Recent Review Date (Revised): 8/10/2020 Effective Date: 11/1/2020 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER REFERENCES CODING INFORMATION POLICY HISTORY I. POLICY Genetic testing for hereditary hearing loss mutations (GJB2, GJB6 and other hereditary hearing loss-related genes) in individuals with suspected hearing loss to confirm the diagnosis of hereditary hearing loss (see Policy Guidelines) may be considered medically necessary. Preconception genetic testing (carrier testing) for hereditary hearing loss–related genes (GJB2, GJB6 and other hereditary hearing loss related genes) in parents may be considered medically necessary when at least one of the following conditions has been met: Offspring with hereditary hearing loss; OR One or both parents with suspected hereditary hearing loss; OR First- or second-degree relative affected with hereditary hearing loss; OR First-degree relative with offspring who is affected with hereditary hearing loss Genetic testing for hereditary hearing loss genes is considered investigational for all other situations, including, but not limited to, testing patients without hearing loss (except as addressed in related policies, e.g., MP-7.009 Preimplantation Genetic Testing). There is insufficient evidence to support a conclusion concerning the health outcomes or benefits associated with this procedure. Policy Guidelines Hereditary hearing loss can be classified as syndromic or nonsyndromic. The definition of nonsyndromic hearing loss is hearing loss not associated with other physical signs and symptoms at the time of hearing loss presentation. It is differentiated from syndromic hearing loss, which is hearing loss associated with other signs and symptoms characteristic of a specific syndrome.
    [Show full text]
  • Perkinelmer Genomics to Request the Saliva Swab Collection Kit for Patients That Cannot Provide a Blood Sample As Whole Blood Is the Preferred Sample
    Deafness Non-Syndromic Sensorineural Autosomal Dominant Panel Test Code D4400 Test Summary This test analyzes 30 genes associated with non-syndromic sensorineural autosomal dominant deafness. Turn-Around-Time (TAT)* 3 - 5 weeks Acceptable Sample Types Whole Blood (EDTA) (Preferred sample type) DNA, Isolated Dried Blood Spots Saliva Acceptable Billing Types Self (patient) Payment Institutional Billing Commercial Insurance Indications for Testing Individuals with hearing loss without any other signs or symptoms associated with a genetic condition Family history of hearing loss consistent with autosomal dominant inheritance Test Description This panel analyzes 30 genes that have been associated with autosomal dominant non-syndromic sensorineural deafness. Both sequencing and deletion/duplication (CNV) analysis will be performed on the coding regions of all genes included (unless otherwise marked). All analysis is performed utilizing Next Generation Sequencing (NGS) technology. CNV analysis is designed to detect the majority of deletions and duplications of three exons or greater in size. Smaller CNV events may also be detected and reported, but additional follow-up testing is recommended if a smaller CNV is suspected. All variants are classified according to ACMG guidelines. Condition Description Between 2-3 per 1,000 children in the United States are born with detectable hearing loss in one or both ears. The prevalance of hearing loss increases with age. By age 12, hearing loss affects 1 in 8 individuals. Hearing loss can be caused by both environmental and genetic causes. Non- syndromic hearing loss is a partial or complete loss of hearing that is not associated with other signs or symptoms. Mutations in many genes have been identified in families with autosomal dominant non-syndromic hearing loss.
    [Show full text]